New study aims to find best first treatment for rare blood cancer
NCT ID NCT07258680
First seen Dec 17, 2025 · Last updated May 09, 2026 · Updated 18 times
Summary
This study compares four different chemotherapy combinations as first treatments for peripheral T-cell lymphoma, a rare type of blood cancer. About 114 newly diagnosed patients will receive one of the four regimens to see which works best and has the fewest side effects. The goal is to identify the most effective and safest first-line therapy for this disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL T-CELL LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.